IFN-Alpha Peptide (bs-8995P)

IFN-Alpha Peptide

Quantity size:

500ug

Source:

Synthetic Peptide

Form:

lyophilized powde

Purity:

≥95% (Purified by HPLC)

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

Blocking Peptide of The bs-8995R Antibody

Background:

The genes encoding type I interferons (IFNs), which include 14 IFN-alphagenes (two of which are IFN-alpha1 and IFN-alpha13), one IFN-∫ gene, one IFN-w (also known as IFN-alpha II1) gene and a number of IFN-w pseudogenes, are clustered on human chromosome 9. IFN-alpha and -beta are cytokines that are widely known to induce potent antiviral activity. They exert a variety of other biological effects, including antitumor and immunomodulatory activities and are increasingly used clinically to treat a range of malignancies, myelodysplasias and autoimmune diseases. IFN-w is antigenically different from human IFN-alpha, IFN-beta or IFN-gamma, but is a component of natural mixtures of IFN species produced by virus-induced leukocytes or Burkitt's lymphoma cells. The type I interferon receptor (IFN-alphaR) interacts with IFN-alpha, IFN-beta and IFN-w, and seems to be a multisubunit receptor.

Also known as:

IFL; IFN alpha; IFN; IFNA; IFNA1; IFNA13; Interferon alpha 1; Interferon alpha 1/13; Interferon alpha 13; Interferon alpha D; Interferon alpha leukocyte; Interferon leukocyte; LeIF D; MGC138207; MGC138505; MGC138507; IFNA1_MOUSE.

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.